Client zone

Johnson & Johnson agree deal to sell Lifescan for $2.1 B

Johnson & Johnson agree to a $2.1 billion offer from private equity shop Platinum Equity for its LifeScan blood glucose monitoring unit. This follows their wrapping up of the insulin pump brand Animas in Q4 of 2017.

Platinum Equity are not new to healthcare having set up SourceOne Healthcare technologies, an imaging products seller, on the back of buying healthcare divisions from Philips and PSS World Medical in 2002.

More at:

https://www.massdevice.com/johnson-johnson-moves-closer-to-exiting-the-diabetes-business-with-2-1b-lifescan-sale/

Referral Scheme

Candidate Tools

Join our Mailing list

G2 Academy

Contact Us

We offer a national recruitment service from our Surrey head office, please see contact details below.

Head Office

PM House,
Riverway Estate
Old Portsmouth Rd
Guildford
GU3 1LZ

T: 01483 910 940
E: sales@g2hr.com

  • 03
  • Mar 2021

Medical device marketers evolve for a post-COVID future

Read More

Work
for Us

Find out More